AffiliationManchester Fungal Infection Group, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, Core Technology Facility, The University of Manchester, Manchester, UK.
MetadataShow full item record
AbstractCRISPR/Cas9 technology enables rapid and efficient genome editing in a variety of experimental systems. Genome editing using CRISPR/Cas9 has become an increasingly popular genetic engineering tool due to (1) an extensive array of commercial ready-to-use CRIPSR/Cas9 systems, (2) improved efficiency of cell delivery, and (3) the possibility to do multigene editing. Here, we describe a method to introduce single gene disruption in lung bronchial epithelial cells. This approach can be used to study host factors important for pathogen interaction or to identify and study genetic markers determining susceptibility to fungal disease.
CitationGago S, Overton NLD, Bowyer P. CRISPR-Cas9-Mediated Gene Silencing in Cultured Human Epithelia. Methods Mol Biol. 2021;2260:37-47.
JournalMethods in Molecular Biology
- Highly efficient gene inactivation by adenoviral CRISPR/Cas9 in human primary cells.
- Authors: Voets O, Tielen F, Elstak E, Benschop J, Grimbergen M, Stallen J, Janssen R, van Marle A, Essrich C
- Issue date: 2017
- CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
- Authors: Vermersch E, Jouve C, Hulot JS
- Issue date: 2020 Apr 1
- CRISPR-Cas systems: ushering in the new genome editing era.
- Authors: Perez Rojo F, Nyman RKM, Johnson AAT, Navarro MP, Ryan MH, Erskine W, Kaur P
- Issue date: 2018
- CRISPR-Cas9 in genome editing: Its function and medical applications.
- Authors: Khadempar S, Familghadakchi S, Motlagh RA, Farahani N, Dashtiahangar M, Rezaei H, Gheibi Hayat SM
- Issue date: 2019 May
- Disabling Cas9 by an anti-CRISPR DNA mimic.
- Authors: Shin J, Jiang F, Liu JJ, Bray NL, Rauch BJ, Baik SH, Nogales E, Bondy-Denomy J, Corn JE, Doudna JA
- Issue date: 2017 Jul